Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease

OBJECTIVE: The Insulin Resistance Intervention after Stroke (IRIS) trial recently found that pioglitazone reduced risk for stroke and myocardial infarction in patients with insulin resistance but without diabetes who had had a recent ischemic stroke or transient ischemic attack (TIA). This report pr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Main Authors: Inzucchi, Silvio E., Viscoli, Catherine M., Young, Lawrence H., Furie, Karen L., Gorman, Mark, Lovejoy, Anne M., Dagogo-Jack, Samuel, Ismail-Beigi, Faramarz, Korytkowski, Mary T., Pratley, Richard E., Schwartz, Gregory G., Kernan, Walter N.
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2016
Assuntos:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5033078/
https://ncbi.nlm.nih.gov/pubmed/27465265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-0798
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares